Return
GABA takes the edge off anti-tumour immunity
G
DOI:10.1038/s41568-026-00963-7.png)
Abstract
En 中文
Glioblastoma exhibits sex-specific differences in disease progression, incidence and immune regulation. Now, Pathak et al. identify GABA (γ-aminobutyric acid) as a key driver of granulocytic myeloid-derived suppressor cell-mediated glioblastoma progression in women.
Journal
IF:
66.8
Papers:
3.8K
Citations:
6.0W
